首页 正文

Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain

{{output}}
Opioids are commonly prescribed for the management of moderate to severe pain, but their use is associated with dependency and other adverse effects. For decades, the development of safe and effective non-addictive alternatives for treating moderate to severe ... ...